Hospira has voluntarily suspended shipments of two drugs – Propofol, an anesthesia, and Liposyn, a fat emulsion for low birth weight babies – to address manufacturing concerns raised by FDA in a recent warning letter.
Continue reading "Coming in Wednesday's "The Pink Sheet" DAILY - Legal Updates for Merck, AstraZeneca" »
Merck unveils integrated late-stage pipeline, including 40 Phase II and Phase III medicines of which eight are in the areas of cardiovascular or infectious disease.
Continue reading "Coming In Tuesday's "The Pink Sheet" DAILY - Merck Pipeline News and FDA Advisory Committee Mtgs. On Tap" »
Salix's Xifaxan for hepatic encephalopathy passed advisory committee review, but members expressed unease about lingering safety concerns and called for additional studies. read_more_>
Continue reading "Latest News from "The Pink Sheet" DAILY - Salix's Xifaxan Advisory Panel Review" »
Company unveils data at European conference supporting use in women ages 27 through 45; data was sent to FDA late last year.
read more
Continue reading "Latest News from "The Pink Sheet" DAILY -- Merck Unveils Gardasil Data" »
A collection of dispatches from the J.P. Morgan health care conference in San Francisco.
read more
Continue reading "Latest News from "The Pink Sheet" DAILY" »
Full article reprinted from The RPM Report July 28, 2009
A common theme for reform advocates in 2009 is avoiding the mistakes
that doomed the Clinton health care reform effort 15 years ago. The
biggest lesson of all is that the consequences of failure would be
critical to the Obama Administration. Read more...
Continue reading "The Long Shadow of HillaryCare" »
Article reprinted from The RPM Report May 19, 2009
Biosimilars haven’t had a huge impact in Europe—yet. Sponsors and analysts expect that to change over time. Will the US market parallel the European experience? Read on...
Continue reading "European Biosimilars’ Market Performance Mirrors US Legislative Progress: Slow but Steady " »
May 5, 2009
In the face of the current swine flu outbreak, Elsevier Business Intelligence remains on top of the latest news, providing you with all the insight and analysis you need to know on how our industry is affected.
Article titles include:
~Vaccine For Swine Flu Faces Multiple Decision Points By Government
~Flu Headlines Challenge New FDA Heads
~FDA Chief Scientist Goodman Spearheads Agency Response to Swine Flu
Read this exclusive coverage now...
Continue reading "Special Edition with Expanded Coverage on the Swine Flu Outbreak from "The Pink Sheet" and Inteleos " »